Related Experiment Video
Updated: Apr 25, 2026
11:19
Robotic Myotomy and Partial Fundoplication for Achalasia
Published on: August 11, 2023
2.3K
Management strategies for achalasia
1Division of Gastroenterology and Hepatology, Mayo Clinic Arizona, Scottsdale, AZ, USA.
Neurogastroenterology and Motility
|August 30, 2014
Summary
Achalasia treatment options include dilation and myotomy, offering similar effectiveness. Patient factors and expertise guide the best choice for managing this esophageal motility disorder.
Area of Science:
- Gastroenterology
- Esophageal Motility Disorders
Background:
- Achalasia management involves pharmacologic therapy, botulinum toxin injection, pneumatic dilation, and myotomy.
- Oral agents are rarely used due to low efficacy and side effects.
- Botulinum toxin offers short-term relief but is not a definitive treatment.
Purpose of the Study:
- To review current achalasia treatment options.
- To discuss the effectiveness and limitations of various therapies.
- To highlight factors influencing treatment selection and future research directions.
Main Methods:
- Review of existing literature on achalasia treatments.
- Comparison of efficacy and safety data for different therapeutic modalities.
- Analysis of factors influencing treatment choice and outcomes in relapsed patients.
Main Results:
- Pneumatic dilation and surgical myotomy are the most effective treatments, with comparable outcomes up to 2 years.
- Treatment selection is individualized based on patient characteristics, preferences, and local expertise.
- Peroral endoscopic myotomy shows promise, but requires further randomized trials.
- Achalasia subtypes may guide treatment, pending prospective validation.
Conclusions:
- Pneumatic dilation and myotomy are current gold standards for achalasia.
- Individualized treatment selection is crucial for optimal patient outcomes.
- Further research, particularly randomized trials, is needed for emerging therapies like peroral endoscopic myotomy and subtype-guided treatment.
Related Concept Videos
01:27Esophageal Achalasia
35
Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide...
35
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
1.9K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.9K
01:26Peptic Ulcer Disease IV: Management
798
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
798
01:26Esophageal Strictures-II: Clinical Features and Management
1.1K
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
1.1K
01:25Peptic Ulcer Disease V: Surgical Management and Nursing Care
1.3K
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
1.3K
01:29Gastroesophageal Reflux Disease II: Clinical Features and Management
1.1K
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
1.1K